Stride, Inc. logo LRN - Stride, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 5
HOLD 10
SELL 2
STRONG
SELL
0
| PRICE TARGET: $109.50 DETAILS
HIGH: $125.00
LOW: $94.00
MEDIAN: $109.50
CONSENSUS: $109.50
UPSIDE: 23.55%

Stock News

AI's Impact On Stride/K12

AI's Impact On Stride/K12

Stride (LRN) has stabilized after LMS challenges, with the stock up 34% since January and operational concerns largely resolved. AI presents both opportunity and risk: it could erode curriculum value but also strengthen LRN's K12 brand as a discovery moat in an AI-driven world. LRN's bundled service model and high switching costs protect against near-term customer attrition, but pricing pressure may emerge if curriculum lags the alternative, necessitating further investment in curriculum development.

Apr 22, 2026 01:06 AM seekingalpha.com
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health

Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated Gestational Age (GA) Tool integrated into its handheld ultrasound solution. This marks the first FDA-cleared blind-sweep ultrasound AI tool for estimating gestational age.

Mar 30, 2026 04:00 AM businesswire.com

Price Targets